Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events

Research output: Contribution to journal › Article › Academic › peer-review

41 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	294-301
Number of pages	8
Journal	Clinical Pharmacology & Therapeutics
Volume	72
DOIs	https://doi.org/10.1067/mcp.2002.127113
Publication status	Published - 2002

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{dd2eac4b0fd2472b94569b9a675754c8,

title = "Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events",

author = "\{van Riemsdijk\}, MM and MCJM Sturkenboom and JM Ditters and RJ Ligthelm and D Overbosch and Bruno Stricker",

year = "2002",

doi = "10.1067/mcp.2002.127113",

language = "Undefined/Unknown",

volume = "72",

pages = "294--301",

journal = "Clinical Pharmacology \& Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events

AU - van Riemsdijk, MM

AU - Sturkenboom, MCJM

AU - Ditters, JM

AU - Ligthelm, RJ

AU - Overbosch, D

AU - Stricker, Bruno

PY - 2002

Y1 - 2002

U2 - 10.1067/mcp.2002.127113

DO - 10.1067/mcp.2002.127113

M3 - Article

SN - 0009-9236

VL - 72

SP - 294

EP - 301

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

ER -